Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clotting disorders and placental abruption: homocysteine--a new risk factor.

European journal of obstetrics, gynecology, and reproductive biology - 1 Apr 2001

Eskes T K

Abstract excerpt

Placental abruption is due to the rupture of the uterine spiral artery. The placenta separates totally or partially from the uterine wall during pregnancy. This serious syndrome has a great risk for the mother (shock and disseminated intravascular coagulation) and her child (mortality or morbidity). To the known risk factors like hypertension, the use of cocaine and smoking, homocysteine is recognized as an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Disorders
Share to Endothelium, Vascular
Share to Fetal Growth Retardation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Folic Acid

Share to Hyperhomocysteinemia

Share to Methionine

Share to Oxidoreductases Acting on CH-NH Group Donors

Share to Pregnancy Complications, Hematologic

Source

Identifiers

PMID: 11301173
DOI: 10.1016/s0301-2115(00)00492-9

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clotting disorders and placental abruption: homocysteine--a new risk factor.PMID 11301173Read ↗

Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.Semantic proximity Read ↗

Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies.Semantic proximity Read ↗

Clinical chemistry and molecular biology of homocysteine metabolism: an update.Semantic proximity Read ↗

Effect of homocysteine on pregnancy: A systematic review.Semantic proximity Read ↗

Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defectsSemantic proximity Read ↗

Role of polymorphisms in factor V (FV Leiden), prothrombin, plasminogen activator inhibitor type-1 (PAI-1), methylenetetrahydrofolate reductase (MTHFR) and cystathionine β-synthase (CBS) genes as risk factors for thrombophilias.Semantic proximity Read ↗

[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].Semantic proximity Read ↗

Homocysteine and stroke.Semantic proximity Read ↗

Homocysteine: evidence for a causal relationship with cardiovascular disease.Semantic proximity Read ↗

A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy.Semantic proximity Read ↗

Homocysteine metabolism.Semantic proximity Read ↗

Vasculopathic and thrombophilic risk factors for spontaneous preterm birth.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.